BA   187.94 (+4.43%)
BA   187.94 (+4.43%)
BA   187.94 (+4.43%)
BA   187.94 (+4.43%)
Log in

OTCMKTS:ELOXEloxx Pharmaceuticals News Headlines

$2.89
+0.18 (+6.64 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.74
Now: $2.89
$2.89
50-Day Range
$2.71
MA: $3.21
$3.65
52-Week Range
$1.44
Now: $2.89
$9.42
Volume39,900 shs
Average Volume159,501 shs
Market Capitalization$115.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Eloxx Pharmaceuticals (OTCMKTS ELOX) News Headlines

Source:
DateHeadline
Eloxx Pharma up 12% on published data supporting rationale of lead drugEloxx Pharma up 12% on published data supporting rationale of lead drug
seekingalpha.com - July 15 at 6:26 PM
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Pharmacology and Experimental TherapeuticsEloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Pharmacology and Experimental Therapeutics
finance.yahoo.com - July 15 at 1:26 PM
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Receives Consensus Rating of "Buy" from BrokeragesEloxx Pharmaceuticals (OTCMKTS:ELOX) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 12 at 3:58 AM
Why Eloxx's Stock Is Trading Higher TodayWhy Eloxx's Stock Is Trading Higher Today
finance.yahoo.com - June 18 at 6:56 PM
Why Eloxxs Stock Is Trading Higher TodayWhy Eloxx's Stock Is Trading Higher Today
www.benzinga.com - June 18 at 1:55 PM
Price Over Earnings Overview: Eloxx PharmaceuticalsPrice Over Earnings Overview: Eloxx Pharmaceuticals
finance.yahoo.com - June 18 at 1:55 PM
Eloxx Pharma up big on restart of cystic fibrosis studyEloxx Pharma up big on restart of cystic fibrosis study
seekingalpha.com - June 17 at 7:12 PM
BRIEF-Eloxx Pharmaceuticals Says Enrollment In Phase 2 Clinical Trial In Cystic Fibrosis Has Resumed In Israel And EuropeBRIEF-Eloxx Pharmaceuticals Says Enrollment In Phase 2 Clinical Trial In Cystic Fibrosis Has Resumed In Israel And Europe
www.reuters.com - June 17 at 7:12 PM
Hedge Funds Are Selling Eloxx Pharmaceuticals, Inc. (ELOX)Hedge Funds Are Selling Eloxx Pharmaceuticals, Inc. (ELOX)
finance.yahoo.com - May 27 at 3:15 PM
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q1 2020 Results - Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 1:50 AM
Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2020 Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 8 at 4:29 PM
Eloxx Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results and Provides Business Update
finance.yahoo.com - May 7 at 4:20 PM
Edited Transcript of ELOX earnings conference call or presentation 5-Mar-20 9:30pm GMTEdited Transcript of ELOX earnings conference call or presentation 5-Mar-20 9:30pm GMT
finance.yahoo.com - March 11 at 5:59 PM
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2019 Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q4 2019 Earnings Call Transcript
www.fool.com - March 6 at 1:34 AM
Eloxx Pharmaceuticals EPS beats by $0.06Eloxx Pharmaceuticals EPS beats by $0.06
seekingalpha.com - March 5 at 7:03 PM
BRIEF-Eloxx Pharmaceuticals Says Board Approved Leadership And Organizational Re-AlignmentBRIEF-Eloxx Pharmaceuticals Says Board Approved Leadership And Organizational Re-Alignment
www.reuters.com - February 27 at 11:50 PM
BRIEF-Eloxx Strengthens Its Commitment To Cystic Fibrosis Through Reallocating ResourcesBRIEF-Eloxx Strengthens Its Commitment To Cystic Fibrosis Through Reallocating Resources
www.reuters.com - February 26 at 11:24 PM
Eloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating ResourcesEloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating Resources
finance.yahoo.com - February 26 at 6:24 PM
Rett Syndrome Therapeutics Market Sky-high projectionRett Syndrome Therapeutics Market Sky-high projection
www.marketwatch.com - January 30 at 1:46 PM
Eloxx Pharmaceuticals (ELOX) Presents At Biotech Showcase 2020 - SlideshowEloxx Pharmaceuticals (ELOX) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 15 at 10:19 PM
BRIEF-Eloxx Pharmaceuticals Provides Update On Progress Of Phase 2 Clinical Programs For Elx-02 And ERSG PipelineBRIEF-Eloxx Pharmaceuticals Provides Update On Progress Of Phase 2 Clinical Programs For Elx-02 And ERSG Pipeline
www.msn.com - January 15 at 12:18 PM
Eloxx Pharma down 30% on underwhelming data on lead candidateEloxx Pharma down 30% on underwhelming data on lead candidate
seekingalpha.com - January 14 at 9:16 PM
Eloxx Pharmaceuticals to Present at the Biotech Showcase™ 2020 on January 14, 2020Eloxx Pharmaceuticals to Present at the Biotech Showcase™ 2020 on January 14, 2020
finance.yahoo.com - December 18 at 7:45 AM
Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue?Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue?
finance.yahoo.com - December 6 at 8:58 AM
Eloxx Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference on December 3rd, 2019Eloxx Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference on December 3rd, 2019
finance.yahoo.com - November 18 at 9:21 AM
Edited Transcript of ELOX earnings conference call or presentation 5-Nov-19 9:30pm GMTEdited Transcript of ELOX earnings conference call or presentation 5-Nov-19 9:30pm GMT
finance.yahoo.com - November 16 at 6:48 PM
BRIEF-Eloxx Pharmaceuticals Reports Q3 Loss Per Share Of $0.32BRIEF-Eloxx Pharmaceuticals Reports Q3 Loss Per Share Of $0.32
www.msn.com - November 7 at 7:29 PM
Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019
finance.yahoo.com - November 7 at 2:28 PM
Eloxx Pharmaceuticals, Inc. (ELOX) Q3 2019 Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 6 at 2:34 AM
Eloxx Pharmaceuticals EPS beats by $0.07Eloxx Pharmaceuticals EPS beats by $0.07
seekingalpha.com - November 5 at 4:21 PM
Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update
finance.yahoo.com - November 5 at 4:21 PM
Eloxx Pharmaceuticals Presents Positive Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)Eloxx Pharmaceuticals Presents Positive Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)
finance.yahoo.com - October 31 at 12:44 PM
Eloxx Pharmaceuticals IncEloxx Pharmaceuticals Inc
www.bloomberg.com - October 24 at 11:47 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
www.prnewswire.com - October 23 at 12:40 PM
Eloxx Pharmaceuticals (ELOX) Presents At Cantor Healthcare Conference - SlideshowEloxx Pharmaceuticals (ELOX) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 4 at 4:19 PM
BRIEF-Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation To Provide Funding And Support For ELX-02 U.S. Phase 2 Clinical TrialBRIEF-Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation To Provide Funding And Support For ELX-02 U.S. Phase 2 Clinical Trial
www.msn.com - September 23 at 10:13 PM
Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare  Conference on October 3rd, 2019Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare  Conference on October 3rd, 2019
finance.yahoo.com - September 16 at 5:08 PM
Vertex Gains Reimbursement for Orkambi & Symkevi in ScotlandVertex Gains Reimbursement for Orkambi & Symkevi in Scotland
finance.yahoo.com - September 13 at 9:50 PM
Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019
finance.yahoo.com - September 10 at 11:10 AM
Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2
www.nasdaq.com - August 26 at 11:56 AM
Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019
finance.yahoo.com - August 26 at 11:56 AM
Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019
finance.yahoo.com - August 13 at 11:46 AM
Eloxx Pharmaceuticals (ELOX) Presents At Canaccord Genuity Growth Conference - SlideshowEloxx Pharmaceuticals (ELOX) Presents At Canaccord Genuity Growth Conference - Slideshow
seekingalpha.com - August 12 at 4:02 PM
Eloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call TranscriptEloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 8 at 4:18 PM
Edited Transcript of ELOX earnings conference call or presentation 7-Aug-19 12:30pm GMTEdited Transcript of ELOX earnings conference call or presentation 7-Aug-19 12:30pm GMT
finance.yahoo.com - August 8 at 12:03 AM
Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business UpdateEloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update
finance.yahoo.com - August 7 at 1:03 PM
Eloxx Pharma begins mid-stage trial for ELX-02 in cystinosisEloxx Pharma begins mid-stage trial for ELX-02 in cystinosis
seekingalpha.com - August 5 at 4:13 PM
Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX-02 in CystinosisEloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX-02 in Cystinosis
finance.yahoo.com - August 5 at 9:40 AM
BRIEF-Eloxx Pharmaceuticals Says An IND For ELX-02 In Cystic Fibrosis Is Now Open In The U.S.BRIEF-Eloxx Pharmaceuticals Says An IND For ELX-02 In Cystic Fibrosis Is Now Open In The U.S.
www.msn.com - July 31 at 8:30 PM
Eloxx Pharmaceuticals Announces Open...Eloxx Pharmaceuticals Announces Open...
www.benzinga.com - July 31 at 12:59 PM
This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.